Show Summary Details
Page of

Conclusion: New roles and relationships in a new innovation ecosystem 

Conclusion: New roles and relationships in a new innovation ecosystem
Conclusion: New roles and relationships in a new innovation ecosystem

Richard Barker

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 06 June 2020

The result of the proposals in this book is a new ecosystem for medical innovation in which many of the participants play new roles. Life science academics will focus to a greater extent on the potential impact of their work. Companies in industry will see more collaborations and partnerships both with academia and with each other. Patient groups and research charities will increasingly be drivers of innovation. Health systems will move from being passive recipients of innovation to being active participants in development. New entrants, mainly from the IT world, will carve out new businesses in patient selection and support and in treatment analysis. To bring all this about, we need ambitious 5- and 10-year goals covering areas from global convergence on evidence needs to a new concordat on patient data access and security.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.